CLINICAL_TRIALS
trial_result
· 2019-03-21
Clinical Trial Update: A Study of LY3113593 in Participants With Chronic Kidney Disease [Phase 1]
Summary
Phase 1 trial update for LY3113593 in participants with chronic kidney disease has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Chronic Kidney Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-03-21